Mullerectomy: Indications, Anatomy, and Surgical Steps

A mullerectomy, more formally called Müller’s muscle-conjunctival resection (MMCR), is a posterior-approach eyelid surgery that corrects ptosis (drooping of the upper eyelid) by removing a strip of Müller’s muscle and the overlying conjunctiva from the inside of the lid. The procedure avoids a visible skin incision, relies on the eyelid’s own smooth muscle anatomy, and works best in patients with moderate-to-good levator function whose lids respond to a phenylephrine eye drop test. Reported success rates range from roughly 72% to 95% depending on how strictly “success” is defined, and the operation has become one of the two dominant approaches to involutional and mild-to-moderate ptosis repair.

Where Müller’s Muscle Sits and What It Does

The superior tarsal muscle, commonly called Müller’s muscle, is a thin sheet of smooth muscle tucked between the main eyelid elevator (the levator palpebrae superioris) and the conjunctiva that lines the inside of the upper lid. It originates from the undersurface of the levator and inserts onto the upper edge of the tarsal plate, the stiff cartilage-like skeleton of the eyelid.¹ Unlike the levator, which is a striated (voluntary) muscle controlled by the oculomotor nerve, Müller’s muscle is a sympathetically innervated smooth muscle. Signals from the cervical sympathetic chain keep it in a low-level state of contraction, contributing roughly 2 mm of lid elevation on top of whatever the levator provides.²

That sympathetic drive is the reason Müller’s muscle matters clinically. When the sympathetic supply is interrupted, as in Horner’s syndrome, the lid drops by that same couple of millimeters. Conversely, when you place a sympathomimetic drop like phenylephrine on the eye, the muscle contracts more forcefully and the lid lifts. That pharmacological response forms the basis of preoperative patient selection for MMCR.

Müller’s muscle also participates in a reflex loop that may surprise people unfamiliar with eyelid physiology. Mechanoreceptors embedded in the muscle detect stretch when the levator contracts; this stretch triggers a continuous reflex contraction of the levator’s slow-twitch fibers through a trigeminal-oculomotor pathway, helping sustain lid elevation without conscious effort.³ This reflex may partly explain why resecting the muscle still improves lid position even in cases where the muscle itself is non-functional.

Who Is a Good Candidate

The classic indication for MMCR is mild-to-moderate involutional (age-related) ptosis in a patient with good levator function. The cornerstone screening tool is the phenylephrine test: one drop of 2.5% or 10% phenylephrine is placed on the conjunctiva of the ptotic eye, and the examiner watches for the lid to rise. A positive response, traditionally defined as at least 1.5 to 2 mm of elevation, suggests that the Müller’s muscle is viable enough for the posterior-approach resection to work.

The test is useful but imperfect. One study found that phenylephrine testing consistently underestimated the correction eventually achieved at surgery, meaning the drop sometimes predicted a smaller improvement than the patient actually got.⁴ Part of the explanation appears to be biological variation in adrenergic receptors: the degree of lid elevation with phenylephrine inversely correlates with the density of alpha-2C receptors in the muscle tissue, so two patients with similar anatomy can respond differently to the same drop.⁵

Beyond the phenylephrine test, surgeons measure the margin-reflex distance (MRD1, the distance from the upper lid margin to the corneal light reflex) and levator excursion (how far the lid moves from full downgaze to full upgaze). A large multicenter prospective study found that the pre-drop MRD1 was the single strongest predictor of surgical success, even more reliably than the phenylephrine response itself.⁶ Preoperative digital photography to document brow position and lid height on both sides has become routine, particularly in unilateral ptosis, because correcting one eye can unmask a compensatory brow elevation on the same side or even change the opposite lid’s position through Hering’s law (the brain’s equal-innervation signal to both levators).⁷

Step-by-Step Surgical Technique

MMCR is typically performed under local anesthesia with sedation, sometimes under straight local in cooperative patients. The key advantage of a posterior approach is that the surgeon works from the conjunctival (inner) surface of the lid, leaving no external skin scar. Here is what happens in the operating room.

A traction suture is placed through the central lid margin, passing through the tarsus and skin. The surgeon uses this suture to evert the upper lid over a Desmarres retractor or a cotton-tipped applicator, exposing the pink conjunctival surface. With the lid flipped, the conjunctiva and underlying Müller’s muscle are elevated and a specialized clamp (the Putterman clamp) is applied along the superior border of the tarsus. The clamp has small needles that anchor the sandwiched tissue and prevent slippage, ensuring that the exact planned amount of tissue will be excised.⁸

A running suture, usually 6-0 plain gut, is passed from the lateral lid through skin and out the conjunctival side near the upper edge of the tarsus, then run medially just below the clamp’s inferior jaw. The suture crosses the full width of the clamped tissue, then runs back laterally in a second pass. Once both passes are complete, the tissue above the suture line and below the clamp jaws is excised with a blade. The clamp is removed, the suture is tied, and the knot is externalized onto the skin side so it does not rub against the eye.⁸ Plain gut suture dissolves on its own within a few weeks, so removal is usually unnecessary.

Some surgeons have shifted to fibrin glue (tissue adhesive) instead of sutures to close the resection bed. A review of a large retrospective series found that fibrin sealant produced equivalent lid position and symmetry to suture closure, with fewer major postoperative complications.⁹ Glue eliminates suture-related irritation entirely, though not every facility stocks it routinely.

Deciding How Much Tissue to Remove

Getting the right amount of resection is the intellectual heart of the operation. A standard starting algorithm uses the phenylephrine test result as a guide: if the drop produces the desired lid height, roughly 9 mm of conjunctiva and Müller’s muscle is resected. If the drop undercorrects, 10 mm is taken; if it overcorrects, 8 mm.¹⁰ This “8-9-10” framework is a useful starting point, but surgeons adjust based on experience and anatomical findings at surgery.

For patients with more than about 3 mm of ptosis who still show a reasonable phenylephrine response, a modified algorithm adds tarsectomy (removal of a strip of the tarsal plate itself) on top of the standard conjunctival-Müller resection. The formula adds tarsus at a roughly one-to-one ratio: for every millimeter the phenylephrine test undercorrects, one additional millimeter of tarsus is excised. This expansion allowed MMCR to reach into moderate-to-severe ptosis territory that was once considered exclusively the domain of levator advancement.¹¹

Interestingly, the raw millimeters of tissue resected correlate only loosely with the actual change in lid height. One study found only a weak statistical association between resection length and postoperative MRD1 change, and on multivariate analysis the preoperative MRD1 was the only significant predictor of the final outcome.¹² In practical terms, that means the starting lid position matters more than exactly how aggressively you cut. It is a humbling finding that keeps ptosis surgery partly art and partly science.

What the Numbers Say About Outcomes

Published success rates for MMCR vary with how strictly success is defined. A large review of more than 300 eyelids treated with isolated subtotal Müller’s muscle resection found that 92% met all three criteria for success (adequate height, good contour, and symmetry with the fellow eye) at an average of four months, and 95% met them at a mean of nearly four years. The average lid height improvement was about 2.5 mm. Over 99% of lids had an excellent contour, and the reoperation rate was just 2%.¹³ That long-term stability is worth highlighting: about half the lids actually continued to rise slightly over time rather than dropping back, and only about a third drifted down, none by more than 1 mm.

A multicenter prospective study defined success more conservatively (MRD1 within a narrow target range) and reported a 72% success rate across 229 eyelids, with symmetry success in about 76% of patients.⁶ The gap between 72% and 95% largely reflects different success thresholds rather than different surgical quality. Either way, the procedure delivers meaningful improvement for the large majority of appropriately selected patients.

A study specifically looking at whether MMCR could handle varying degrees of ptosis, not just mild cases, found no significant difference in levator function between the surgical-success and surgical-failure groups, suggesting that the operation works across a range of ptosis severity as long as patients are properly selected.¹⁴

MMCR Versus External Levator Advancement

The main alternative to MMCR is external levator advancement (ELA), which approaches the lid from the skin side and directly tightens or reattaches the levator aponeurosis. Choosing between the two is one of the central decisions in ptosis surgery.

Head-to-head, one comparative study found the success rate was higher with MMCR (about 92%) than with levator advancement (about 72%). No overcorrections occurred in the MMCR group, while roughly 9% of levator advancement patients were overcorrected. Lid contour abnormalities appeared only in the levator group.¹⁵ These findings favor MMCR for mild-to-moderate ptosis, though the study populations were not identical: levator advancement patients tend to present with more severe drooping, which makes the comparison uneven. A separate study confirmed that levator advancement patients had significantly worse ptosis preoperatively yet achieved similar postoperative lid positions, suggesting the external approach is better suited for severe cases.¹⁶

For the outcome patients care most about, symmetry, a quantitative comparison in unilateral ptosis found that the two approaches are equally effective at achieving symmetric lid position and contour peak location.¹⁷ So the practical takeaway is that MMCR and levator advancement are complementary tools rather than competitors: MMCR for mild-to-moderate ptosis with a good phenylephrine response, levator advancement for more severe cases or when the phenylephrine test is negative.

Complications and What Happens When It Undercorrects

Serious complications after MMCR are uncommon. In one series, the overall complication rate was about 4%, and the most frequent issues were minor. A small study reported dry eyes in one patient (treated with lubricating drops) and suture-related discomfort in two, both of which resolved once the suture was removed. No corneal abrasions were observed.¹⁸ The conjunctival surface heals quickly because of its rich blood supply; the eyelid has multiple arterial arcades that feed perforating branches through both sides of the tarsal plate.¹⁹

The most clinically significant “complication” is undercorrection, where the lid does not reach the target height. When that happens, revision surgery is feasible. A case series of 18 eyelids revised for undercorrection after MMCR found that repeat MMCR and external levator repair both produced acceptable lid elevation with low complication rates.²⁰ Overcorrection, by contrast, is rare with MMCR since the lid is not being actively retracted by a stitch tied under tension. This asymmetry in risk, undercorrection being much more common than overcorrection, is often cited as one of the procedure’s safety advantages.

Horner’s Syndrome and Other Special Situations

Because Müller’s muscle depends on sympathetic innervation, the intuition is that MMCR should not work in Horner’s syndrome, where the sympathetic chain is disrupted. Surprisingly, it does. An early series of six patients with Horner-related ptosis found that five achieved perfectly symmetric lid heights after MMCR, and the sixth was overcorrected by only 0.5 mm. The authors concluded that the mechanism by which MMCR alleviates ptosis is independent of active contraction of the muscle itself.²¹ In other words, the surgery works at least partly by mechanically shortening the posterior lid lamella, not solely by relying on muscle tone.

A more recent series of seven Horner patients confirmed significant improvement (average MRD1 change of 4.0 mm in the ptotic eye), though symmetry was harder to predict. Three of the seven had more than 1 mm of final asymmetry, and the response to phenylephrine testing was more variable than in standard ptosis patients, likely because of the altered sympathetic pharmacology.²² A case report of iatrogenic Horner’s syndrome following jugular vein catheterization similarly found that mullerectomy was effective once six months had passed without spontaneous recovery and the phenylephrine test was positive.²³

The Horner experience underscores a broader point about MMCR: the procedure’s success does not hinge entirely on the muscle’s ability to contract. Mechanical shortening of the posterior lamella, along with whatever residual tone exists, contributes to the final lid position. This is probably why resection length alone is only a weak predictor of outcome; the tissue’s baseline compliance and the patient’s starting anatomy matter just as much.

What the Tissue Reveals Under the Microscope

Surgeons rarely look at their resected tissue under a microscope outside of a research setting, but the histology turns out to contain useful information. A study that graded Müller’s muscle fibrosis in resected specimens found that increasing severity of fibrosis was associated with a slightly greater per-millimeter correction effect. The relationship was statistically significant though small in absolute terms. By contrast, muscle hypertrophy (thickening of the muscle fibers) had no detectable association with surgical outcomes.²⁴ The practical implication is that stiffer, more fibrotic tissue may actually transmit the mechanical shortening more efficiently to the lid margin, helping explain why the operation sometimes works better than expected in patients with longstanding ptosis and presumably more tissue remodeling.

How Patients Feel After Surgery

Functional lid height is what surgeons measure, but what patients care about is how the surgery changes their day-to-day experience. A quality-of-life study using the Glasgow Benefit Inventory, a validated questionnaire designed to measure perceived benefit after an intervention, found that patients averaged a score indicating meaningful improvement, particularly on the question asking about overall quality of life. The highest-scoring item was the one addressing general improvement, while the lowest related to self-consciousness, suggesting that even patients who are pleased with the functional result may still feel somewhat aware of the surgical eye in social situations.²⁵ The questionnaire was administered at an average of nearly two years after surgery, so the responses reflect settled, long-term perceptions rather than the immediate postoperative honeymoon period.

Patients often ask whether the surgery will feel “natural” or whether others will notice something is different. The evidence on contour is reassuring: MMCR consistently produces a smooth, natural lid curve with very low rates of contour abnormalities, especially compared to external approaches. The absence of a skin incision also means there is no visible scar, which matters to patients who came to the procedure for cosmetic reasons in addition to functional ones. Recovery is typically quick, with most people returning to normal activities within a week or two, though mild swelling and bruising along the lid are expected for the first several days.